✦ LIBER ✦

Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer

✍ Scribed by Panagiotis A. Georgiou; Paris P. Tekkis; Vasilis A. Constantinides; Uday Patel; Robert D. Goldin; Ara W. Darzi; R. John Nicholls; Gina Brown

Book ID: 119233322
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 930 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.06.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diagnostic tests in urology: magnetic re

Diagnostic tests in urology: magnetic resonance imaging (MRI) for the staging of prostate cancer

✍ Preston, Mark A.; Harisinghani, Mukesh G.; Mucci, Lorelei; Witiuk, Kelsey; Breau 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

Accuracy of high resolution (1.5 tesla)

Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: Results from a prospective study

✍ Renard-Penna, Raphaële; Rouprêt, Morgan; Comperat, Eva; Ayed, Amine; Coudert, Ma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 667 KB

248 ACCURACY OF MULTIPARAMETRIC MAGNETIC

248 ACCURACY OF MULTIPARAMETRIC MAGNETIC RESONANCE PROSTATE IMAGING (MP-MRI) IN CONFIRMING ELIGIBILITY FOR ACTIVE SURVEILLANCE (AS) FOR MEN WITH PROSTATE CANCER (PCA)

✍ Stamatakis, Lambros; Siddiqui, M. Minhaj; Logan, Jennifer; Nix, Jeffrey; Rais-Ba 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 103 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB